Top Markets
Coin of the day
BNB Plus Corp. BNB Plus Corp.

BNB Plus Corp.

BNBX
Rang in aandelen #38647
BNB Plus Corp., established in 1983 and based in Stony Brook, NY, is a... BNB Plus Corp., established in 1983 and based in Stony Brook, NY, is a biotechnology firm dedicated to pioneering and commercializing technologies for the synthesis and identification of both deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The company's operations are divided into three distinct business segments. Its Therapeutic DNA Production Services division specializes in the enzymatic manufacturing of synthetic DNA, used in the creation of nucleic acid-based treatments, and also develops and markets its proprietary RNA Polymerase (RNAP) for mRNA therapeutic production. The MDx Testing Services segment concentrates on developing clinical molecular diagnostic and genetic assessments, in addition to providing comprehensive clinical laboratory testing services. Lastly, the DNA Tagging and Security Products and Services segment leverages DNA detection techniques for securing industrial supply chains and offering various security solutions.
Aandeelprijs
$0.09
Laatst gesynchroniseerd: 2026-07-28
Marktkapitalisatie
$876.21K
Verandering (1 dag)
0.00%
Verandering (1 jaar)
-97.79%
Land
US
Handel BNB Plus Corp. (BNBX)

Categorie

Koersgeschiedenis voor BNB Plus Corp. (BNBX)
Hoogste slotkoers: $0.20 op 2026-07-01

Laagste slotkoers: $3.96M op 2006-06-01
Koersgeschiedenis van BNB Plus Corp. van 2006 tot 2026
Jaarlijkse koersprestatie
Jaar Prestaties
2026 (TTM) -32.54%
2025 -98.22%
2024 -98.74%
2023 -46.39%
2022 -71.32%
2021 -19.55%
2020 50.29%
2019 -86.89%
2018 -63.54%
2017 2.62%
2016 -37.30%
2015 17.11%
2014 -59.86%
2013 -10.26%
2012 95.00%
2011 22.22%
2010 -26.83%
2009 74.47%
2008 -60.62%
2007 24.71%
2006 0.00%
Aandelenkoers van vergelijkbare bedrijven of concurrenten
Bedrijf Aandelenkoers Verandering 1jr% Land
$507.94 30.14%
US
$846.71 29.78%
NL
$731.69 7.13%
CH
$1.07K -6.40%
KR
$251.82 11.25%
BE